It’s Time to Buy: 1 Oversold TSX Stock Poised for a Comeback

Let’s be clear. Oversold does not mean cheap. It means the market has punished a TSX stock faster than the business has changed, and that gap can create an opportunity. Before you buy, check what caused the drop, whether it is temporary, and whether the TSX stock can fund itself through a slower stretch. Look for real signals, like recurring revenue, improving profitability, and customers that stick around. Then decide your time frame. Oversold trades need patience, and you should size the position as though it could take time. So, let’s look at one to consider.

TCS

Tecsys (TSX:TCS), sells supply chain software to organizations that cannot afford mistakes. It focuses on healthcare providers, distributors, and complex commerce, with a heavy tilt toward hospitals that need tight control over inventory and pharmacy workflows. In short, it helps a network know what it has, where it sits, and what needs to move next. That sounds dull, but dull can pay when customers sign multi-year contracts and avoid switching.

Over the last year, Tecsys delivered a mix of validation and volatility. It expanded access to its flagship Elite platform by listing it on Amazon Workplace Solutions (AWS) Marketplace, which can shorten procurement cycles for customers that already buy cloud tools through that channel. Management also flagged headwinds from the U.S. healthcare policy environment, a government shutdown, and tariff uncertainty, which can slow decisions even when need stays high. The market sold the TSX stock anyway, and momentum turned ugly.

More recently, it published survey findings that pointed to a visibility gap in hospital pharmacies, with only one in five respondents reporting real-time visibility across care settings and most relying on delayed or manual tracking. It also picked up recognition from Modern Healthcare’s Best in Business program for supply chain excellence. These signals don’t guarantee sales, but support demand as shortages and disruptions keep teams under pressure every day.

Earnings support

In the second quarter of fiscal 2026, Tecsys delivered record total revenue of $48.6 million, up from $42.4 million a year earlier. Software as a Service (SaaS) revenue rose 22% to $19.7 million, and professional services revenue grew as implementation work stayed busy. It also posted net profit of $1.8 million, or $0.12 per share, and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of $5 million versus $2.9 million last year. These results show momentum without needing a perfect macro backdrop.

The forward-looking metrics looked even better than the headline profit. SaaS annual recurring revenue (ARR) reached $81.1 million at Oct. 31, 2025, up 16% year over year, and remaining performance obligation climbed 18% to $240.4 million. That backlog can smooth results if new bookings slow for a quarter. Tecsys also maintained full-year fiscal 2026 guidance for total revenue growth, SaaS revenue growth, and adjusted EBITDA margin, which suggests it still sees a steady runway.

So, why does it look oversold? The stock has traded far below its 52-week high, down 46% in the last year as of writing, while trading at 67 times earnings. This valuation does not scream bargain, but the market can compress the multiple quickly when growth scares it, and that pressure can set up a rebound when results hold.

Bottom line

In short, this TSX stock could be a buy for investors who want a comeback built on recurring revenue, not a one-day headline. The path looks simple: keep growing SaaS, keep scaling adjusted EBITDA, and let backlog convert into cash. However, the risks stay real: services can swing, healthcare budgets can stall projects, and the valuation can disappoint if growth slows. If you can handle small-cap volatility and you want a Canadian software name with real traction, TCS deserves a fresh look. If you need deep value today, wait for a pullback first and start small.

The post It’s Time to Buy: 1 Oversold TSX Stock Poised for a Comeback appeared first on The Motley Fool Canada.

Should you invest $1,000 in Tecsys Inc. right now?

Before you buy stock in Tecsys Inc., consider this:

The Motley Fool Canada team has identified what they believe are the top 10 TSX stocks for 2026… and Tecsys Inc. wasn’t one of them. The 10 stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 … if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,827.88!*

Now, it’s worth noting Stock Advisor Canada’s total average return is 102%* – a market-crushing outperformance compared to 81%* for the S&P/TSX Composite Index. Don’t miss out on our top 10 stocks, available when you join our mailing list!

Get the 10 stocks instantly #start_btn6 { background: #0e6d04 none repeat scroll 0 0; color: #fff; font-size: 1.2em; font-family: 'Montserrat', sans-serif; font-weight: 600; height: auto; line-height: 1.2em; margin: 30px 0; max-width: 350px; text-align: center; width: auto; box-shadow: 0 1px 0 rgba(0, 0, 0, 0.5), 0 1px 0 #fff inset, 0 0 2px rgba(0, 0, 0, 0.2); border-radius: 5px; } #start_btn6 a { color: #fff; display: block; padding: 20px; padding-right:1em; padding-left:1em; } #start_btn6 a:hover { background: #FFE300 none repeat scroll 0 0; color: #000; } @media (max-width: 480px) { div#start_btn6 { font-size:1.1em; max-width: 320px;} } margin_bottom_5 { margin-bottom:5px; } margin_top_10 { margin-top:10px; }

* Returns as of January 15th, 2026

More reading

• Where Will Canadian Natural Resources Be in 5 Years?
• Your First Canadian Stocks: How New Investors Can Start Strong in 2026
• 3 Canadian Dividend Stocks Perfect for Retirees
• A 5% Dividend Stock is My Top Pick for Immediate Income
• Get Ready: Up to $109,000 Worth of TFSA Room is Available in 2026!

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Tecsys. The Motley Fool recommends Amazon. The Motley Fool has a disclosure policy.